Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

202189-77-3Bilastine Impurity 12

● Auf Lager

Katalog-Nr.::	VE0012692
CAS-Nr.::	202189-77-3
Summenformel::	C32H44N4O2
Molare Masse::	516.73 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 202189-77-3

Parent drug

Bilastine

IUPAC-Name

2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4, 4-dimethyl-4, 5-dihydrooxazole

Pharmakopöe-Synonyme

N/A

Other Synonyms

4,5-Dihydrooxazole Bilastine

Smile

CC1(C)N=C(C(C)(C2=CC=C(CCN3CCC(C4=NC5=CC=CC=C5N4CCOCC)CC3)C=C2)C)OC1

InChI

InChI=1S/C32H44N4O2/c1-6-37-22-21-36-28-10-8-7-9-27(28)33-29(36)25-16-19-35(20-17-25)18-15-24-11-13-26(14-12-24)32(4,5)30-34-31(2,3)23-38-30/h7-14,25H,6,15-23H2,1-5H3

Beschreibung

Bilastine Impurity 12 is a meticulously characterized reference material that complies with rigorous regulatory requirements, including those defined by USP, EMA, JP, and BP. This product plays a crucial role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Bilastine . It is further supported by a detailed Structure Elucidation Report (SER), ensuring high accuracy and reliability across a broad range of analytical applications.